ConformationX Therapeutics Bolts out of Stealth Securing Over 13.5M in Funding to Propel Its Innovative ImmuneOncology Pipeline
ConformationX Therapeutics LLC an immuneoncology focused drug development company announced today that it has closed an oversubscribed funding tranche of 3.65M bringing the total raised since inception to over 13.5M.